加拿大央行會議紀要：部分委員對中期通脹預期的上行跡象表示擔憂，但所有委員一致認爲長期通脹預期仍保持穩固。

A circulated complaint alleges Kelun-Botai Biotech (06990.HK) and related personnel engaged in commercial bribery linked to its Lukang Shatuo monoclonal antibody. The complaint cites a 2025 list price of 9,399 yuan per vial and names hospitals including Beijing 301 and 307. Alleged inducements include cash kickbacks of 900–2,000 yuan per vial; foundation-anchored directed sponsorship and over 8 mln yuan in service fees to clinical directors; inflated meeting fees; and expensive gifts. Kelun-Botai said the claims are untrue, will verify the complainant and pursue legal liability.

美聯儲主席沃什：尚未開始考慮在傑克遜霍爾演講（8月份）中將涉及的內容。